Cardiovascular Profile
Infectious Disease
Rx to OTC Switches
Infectious Disease


Staffing, Studies and Success

 

IHC's clinical staff of researchers is comprised of experts in many different therapeutic areas, including Vascular and Infectious Disease. Our clinical researchers are from top Pharmaceutical and CRO organizations providing the highest quality study management, monitoring and data management services.

Some Examples of Infectious Disease Studies:

  • Candidiasis - multiple trials (Phase II - IV) involving numerous anti-fungal drugs, including the Gyne-Lotrimin® switch.

  • Duodenal Ulcers - studies involving H. pylori assessment.


  • Chlamydia Trachomatis, Helicobacter Pylori and Clostridium Difficile - studies involving a new class of antimicrobial agents for the treatment and eradication of these pathogens. IHC is responsible for all project management, monitoring, data input, analysis, and cleaning; as well as all regulatory management for three (3) major clinical programs for a new class of antimicrobial agents. This agent targets and inhibits the transcriptional machinery of bacteria. Its development will open up new treatments for severe infections by not only managing the treatment, but also eradicating the bacteria inhibiting future re-infections.
  • Chlamydia Trachomatis, Helicobacter Pylori and Clostridium Difficile - studies involving a new class of antimicrobial agents for the treatment and eradication of these pathogens. IHC is responsible for all project management, monitoring, data input, analysis, and cleaning; as well as all regulatory management of these major clinical programs for a new class of antimicrobial agents. This agent targets and inhibits the transcriptional machinery of bacteria.

Along with our clinical expertise, IHC has supported a number of successful programs using electronic data capture (EDC) technology. We have helped our clients take the necessary steps to become EDC compliant companies and have supported over five (5) EDC research programs. These studies range from small pilot trials to the largest Acute Coronary Syndrome trial conducted (14,000 patients) to-date..


 

Norwalk, CT 06851
Ph: 203-852-8900
Fx: 203-852-1424


info@ihcresearch.com